Company Name, Ticker, Customers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
GALT's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Galectin Therapeutics Inc News
Galectin Therapeutics Inc's ROE
Galectin Therapeutics Inc's Dividend Pay out
Galectin Therapeutics Inc Business Description
Galectin Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Galectin Therapeutics Inc Growth Rates
Galectin Therapeutics Inc Profitability
Galectin Therapeutics Inc Valuation
Galectin Therapeutics Inc Management Effectiveness
Galectin Therapeutics Inc Financial Strength
Galectin Therapeutics Inc Efficiency
Galectin Therapeutics Inc Dividend
Financials
Galectin Therapeutics Inc Business Segments
Galectin Therapeutics Inc Income Statement
Galectin Therapeutics Inc Balance Sheets
Galectin Therapeutics Inc Cash Flow Statement
Galectin Therapeutics Inc Geographic Information
Suppliers
Galectin Therapeutics Inc Suppliers Performance
GALT Suppliers Stock Performance
GALT Suppliers Growth Rates
GALT Suppliers Data
GALT Suppliers Efficiency
GALT Suppliers Management Effectiveness
GALT Suppliers Valuation
GALT Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Galectin Therapeutics Inc Market Share
Galectin Therapeutics Inc Competition Performance
Galectin Therapeutics Inc Competitors Results
GALT Competitors Stock Performance
GALT Competitors Growth Rates
GALT Workforce Efficiency at the Competitors
GALT Competitors Efficiency
GALT Competitors Management Effectiveness
GALT Competitors Valuation
Customers & Markets
Galectin Therapeutics Inc Customers Demand
GALT Customers Expenditure Growth Rates
GALT Customers Performance
GALT Customers Stock Performance
GALT Customers Growth Rates
GALT Workforce Efficiency at the Customers
GALT Customers Efficiency
GALT Customers Management Effectiveness
GALT Customers Valuation
GALT Customers by Companys' Segments
Charts & Quotes
Galectin Therapeutics Inc Comparison Charts
GALT OHLC Charts
GALT's Tehnical Upper Indicators
GALT's Tehnical Lower Indicators
GALT's Weekly Charts
GALT's Monthly Charts
Galectin Therapeutics Inc's Profile
Company Charts and Quotes
Galectin Therapeutics Inc News
Galectin Therapeutics Inc's Geographic Information
Galectin Therapeutics Inc's Income Statement
Galectin Therapeutics Inc's Balance Sheets
Galectin Therapeutics Inc's Cash Flow Statement
Galectin Therapeutics Inc's Profitability
Galectin Therapeutics Inc's Financials
Galectin Therapeutics Inc's Price to Book MRQ
Galectin Therapeutics Inc's Suppliers
Galectin Therapeutics Inc's Competitors
Galectin Therapeutics Inc's Markets & Customers
Galectin Therapeutics Inc's Market Share
GALT's Suppliers Management Effectiveness
GALT's Competitors Results
GALT's Charts Technical Analysis
GALT's Customers Demand
Economic Indicators
Revenue per Employee by Industry
Management Effectiveness Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Money Supply
News
Economy News
Stock News
Transportation Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Galectin Therapeutics Inc
(
GALT
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Galectin Therapeutics Inc 's Yearly Income from Continued Operations Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
GALT Annual Income from Cont. Operations Growth
2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change
-
-
-
-
-
Annual Income from Cont. Operations (in millions $)
$-44.69
$-38.78
$-30.53
$-23.47
$-19.92
GALT Company Profile
>>
Back to GALT Fundamentals at a Glance
>>
Back to GALT Growth Comparisons
Annual Income from Cont. Operations Growth Comment
Galectin Therapeutics Inc
realized loss from Cont. Operations.
Galectin Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector
Y/Y Income from Continued Operations Growth %
2023 Annual Income from Cont. Operations
Merck and Co Inc
-97.49 %
$ 365.000 millions
Avantor Inc
-53.23 %
$ 321.100 millions
Henry Schein Inc
-22.97 %
$ 436.000 millions
Revvity Inc
-64.99 %
$ 179.503 millions
Catalent Inc